"Efficacy of Preoperative mFOLFIRINOX vs mFOLFIRINOX Plus Hypofractionated Radiotherapy for Borderline Resectable Adenocarcinoma of the Pancreas: The A021501 Phase 2 Randomized Clinical Trial" by Michael Chuong

Article

Efficacy of Preoperative mFOLFIRINOX vs mFOLFIRINOX Plus Hypofractionated Radiotherapy for Borderline Resectable Adenocarcinoma of the Pancreas: The A021501 Phase 2 Randomized Clinical Trial

JAMA Oncology

Michael Chuong, Miami Cancer Institute

Download Find in your library

Publication Date

9-1-2022

Content Type

application/pdf

PubMed ID:

35834226

Additional Authors:

Additional authors and institutional affiliations

Citation Information

JAMA Oncol (2022) 8(9):1263-1270